Arcos, Inc. Receives $750k Army Contract for Burn Resuscitation Decision Support System
HOUSTON, June 28, 2011 -- Arcos, Inc. announced today that it entered into a $750k cooperative agreement contract with the U.S. Army Medical Research Acquisition Activity (USAMRAA) to develop the Burn Resuscitation Decision Support System (BRDSS). The BRDSS is a patented decision support tool to aid fluid resuscitation of serious burn victims. The underlying technology was developed by the U.S. Army Institute of Surgical Research (USAISR) Combat Critical Care Engineering (C3E) group and has been in clinical use at the Brooke Army Medical Center in San Antonio for a few years. Arcos' role in the cooperative agreement is to develop and obtain FDA 510(k) clearance for a portable tablet version of the technology.
Jose Salinas, Ph.D., program manager for C3E task area at the USAISR, said, "The BRDSS will allow the clinical expertise of the USAISR burn center to be extended to the critical phase of early treatment and evacuation in a user friendly package that can be easily used by clinical providers. We believe that this system will improve burn care and outcomes for all our soldiers, airmen, sailors, and marines injured in the line of duty."
Chris Meador, CEO of Arcos, added, "We are delighted to be working with the Army on this important project. Many burn victims, inside and outside the Department of Defense, can benefit from an individualized, precise fluid resuscitation. We look forward to continuing the excellent work started at USAISR."
Arcos, Inc. is a Houston, TX based company developing multiple clinical decision support tools. Arcos has licensed two Army-UTMB fluid resuscitation patents as well as sepsis clinical decision support technology. Arcos is a Houston Technology Center Client Company.
The opinions contained herein are the private views of the authors and are not to be construed as official or as reflecting the views of the Department of the Army or the Department of Defense.
Source: Arcos, Inc.
Contact: Chris Meador, CEO